Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PMD

Psychemedics (PMD) Stock Price, News & Analysis

Psychemedics logo

About Psychemedics Stock (NASDAQ:PMD)

Key Stats

Today's Range
$2.46
$2.77
50-Day Range
$2.32
$3.21
52-Week Range
$1.63
$3.25
Volume
113,627 shs
Average Volume
N/A
Market Capitalization
$16.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PMD Stock News Headlines

Psychemedics Releases 2025 Workforce Insights Report
This dark force is about to change everything
An unstoppable force is reshaping America — one so powerful it’s already disrupting how we work, invest, and live. Porter Stansberry calls it The Final Displacement — a rare turning point that’s only happened four times in human history, each one redefining entire eras. His new documentary reveals why this shift could trigger both immense loss and unprecedented opportunity, and what you can do to prepare before it accelerates.tc pixel
Psychemedics announces reverse stock split, forward stock split
Psychemedics reminds stockholders to cast votes for Annual Meeting
See More Headlines

PMD Stock Analysis - Frequently Asked Questions

Psychemedics Corporation (NASDAQ:PMD) released its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.09) earnings per share for the quarter. The company earned $5.20 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Psychemedics investors own include Pfizer (PFE), NVIDIA (NVDA), DraftKings (DKNG), UnitedHealth Group (UNH), Canopy Growth (CGC), Advanced Micro Devices (AMD) and McDonald's (MCD).

Company Calendar

Last Earnings
11/12/2024
Today
10/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PMD
CIK
806517
Employees
140
Year Founded
1985

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$19.68 million
Price / Sales
0.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.84 per share
Price / Book
3.18

Miscellaneous

Outstanding Shares
6,120,000
Free Float
5,266,000
Market Cap
$16.34 million
Optionable
Not Optionable
Beta
N/A

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PMD) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners